Showing results (351-360 of 410) with videos related to
Sort By:
Pageof 41
British Journal of Cancer|July 17, 1998
A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancerT F Hickish, I E Smith, M C Nicolson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatinI E Smith, M E O'Brien, D C Talbot, et al.Surgical Endoscopy|September 5, 2009
Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancerChristopher P Twine, S Ashley Roberts, Wyn G Lewis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomasM Brada, L Viviers, C Abson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2005
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomideM Brada, S Ashley, A Dowe, et al.The Biochemical Journal|April 15, 1997
Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitorsK M Bottomley, N Borkakoti, D Bradshaw, et al.Inorganic Chemistry|July 3, 2020
Phosphorus Analogues of [Ni(bpy)2]: Synthesis and Application in Carbon-Halogen Bond ActivationJ Leitl, P Coburger, D J Scott, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapyL Assersohn, T J Powles, S Ashley, et al.British Journal of Cancer|April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?S Postel-Vinay, H-T Arkenau, D Olmos, et al.British Journal of Cancer|April 16, 2002
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohortC Foster, D G R Evans, R Eeles, et al.Pageof 41